NCT01564706View on ClinicalTrials.gov

A Study of 18F-AV-45 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Alzheimer Disease
Interventions
DRUG

florbetapir F 18

IV injection, 370MBq (10mCi), single dose

Trial Locations (1)

19406

Research Site, Jenkintown

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY